Tag Archives: WHO

MEMORIAM: Dr. Likezo Mubila

Dr. Likezo Mubila

The global health community lost one of its strongest champions last week with the sudden death of Dr. Likezo Mubila. A specialist in neglected tropical diseases for the WHO Africa region, Dr. Mubila was a tireless advocate and partner for organizations and governments seeking to control and eliminate lymphatic filariasis, soil-transmitted helminthiasis and schistosomiasis. Equally at ease in the field as she was among global health policymakers, Dr. Mubila provided a crucial voice on the challenges and opportunities inherent with ridding the world of some of its most pervasive diseases. While we mourn her loss, we also celebrate Dr. Mubila’s legacy and honor the positive impact that her life’s work had on millions of people. For more information on Dr. Mubila, please read the WHO’s official statement on her passing.

WHO research programme on tropical diseases wins Gates Award

The Special Programme for Research and Training in Tropical Diseases (TDR), based at WHO headquarters in Geneva and co-sponsored by UNICEF, UNDP, the World Bank and WHO, has won the 2011 Gates Award for Global Health.
TDR which has been operating since 1975, has supported and advocated for research and development to address infectious diseases and has had a major impact on reducing the burden of onchocerciasis, dengue, malaria, Chagas’ disease and visceral leishmaniasis .TDR will recieve $1 Million as a part of the reward which will go to expanding its fellowship and training programs.

Read the full press release here

The Global Network for Neglected Tropical Diseases Partners with Eisai Co., Ltd.

The Global Network to provide advocacy and resource mobilization support to complement Eisai Co., Ltd.’s historic DEC donation to the World Health Organization (WHO)

March 15, 2011- The Global Network for Neglected Tropical Diseases announced today that it has signed a memorandum of understanding (MOU) with Eisai Co., Ltd to provide advocacy support for Eisai’s diethylcarbamazine (generic name, “DEC”) donation to the World Health Organization (WHO). This donation is a significant contribution to the global neglected tropical disease (NTD) response and will expand the pharmaceutical industry’s role in global health initiatives to combat NTDs.  Through collaboration around advocacy activities related to the DEC donation, the Global Network will assist Eisai in forging and maintaining strong ties with international agencies, foundations, corporate and government agencies working to combat NTDs.  The Global Network will work with Eisai on its planning, reporting, and implementation activities around the DEC donation and will provide Eisai with technical advice for future decision-making on NTD initiatives.  Eisai will work with the Global Network to deepen its engagement in NTD policy, advocacy, and resource mobilization efforts, particularly in Asia.

Continue reading

Reading List 3/10/2011

Interesting reads today in the world of NTDs and global health! Today we’re reading about the pharmaceutical company Sanofi-aventis‘ commitment of $25 million to the World Health Organization (WHO) to control neglected tropical diseases, the nonprofit Bio Ventures for Global Health’s (BVGH) new interactive NTD resource for companies, and the launch of a new collaboration between Anacor Pharmaceuticals and the Institute For OneWorld Health to develop new treatments for diarrheal diseases.

Sanofi and WHO to fight tropical diseases, Pharmaceutical Field
, Spoonful of Medicine
New Collaboration To Develop New Treatments For Diarrheal Disease, MedLexicon